Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains

被引:28
|
作者
Araripe Sucupira, Maria Cecilia [1 ]
Sanabani, Sabri [2 ]
Cortes, Rodrigo M. [1 ]
Giret, Maria Teresa M. [3 ]
Tomiyama, Helena [1 ]
Sauer, Mariana M. [1 ]
Sabino, Ester Cerdeira [4 ]
Janini, Luiz Mario [5 ]
Kallas, Esper Georges [3 ]
Diaz, Ricardo Sobhie [1 ]
机构
[1] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil
[2] Fundacao Pro Sangue, Sao Paulo Blood Bank, Sao Paulo, Brazil
[3] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[4] Univ Sao Paulo, Div Infect Dis, Sao Paulo, Brazil
[5] Univ Fed Sao Paulo, Div Microbiol, Sao Paulo, Brazil
来源
PLOS ONE | 2012年 / 7卷 / 01期
关键词
VIRUS TYPE-1 SUBTYPES; T-CELL-ACTIVATION; HEPATITIS-G VIRUS; ANTIRETROVIRAL THERAPY; GENETIC RESTRICTION; ENZYME-IMMUNOASSAY; CORECEPTOR USAGE; PROGNOSTIC VALUE; AIDS; VARIANTS;
D O I
10.1371/journal.pone.0030292
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Primary HIV infection is usually caused by R5 viruses, and there is an association between the emergence of CCXR4-utilizing strains and faster disease progression. We characterized HIV-1 from a cohort of recently infected individuals in Brazil, predicted the virus's co-receptor use based on the env genotype and attempted to correlate virus profiles with disease progression. Methods: A total of 72 recently infected HIV patients were recruited based on the Serologic Testing Algorithm for Recent HIV Seroconversion and were followed every three to four months for up to 78 weeks. The HIV-1 V3 region was characterized by sequencing nine to twelve weeks after enrollment. Disease progression was characterized by CD4+ T-cell count decline to levels consistently below 350 cells/mu L. Results: Twelve out of 72 individuals (17%) were predicted to harbor CXCR4-utilizing strains; a baseline CD4,350 was more frequent among these individuals (p = 0.03). Fifty-seven individuals that were predicted to have CCR5-utilizing viruses and 10 individuals having CXCR4-utilizing strains presented with baseline CD4.350; after 78 weeks, 33 individuals with CCR5 strains and one individual with CXCR4 strains had CD4.350 (p = 0.001). There was no association between CD4 decline and demographic characteristics or HIV-1 subtype. Conclusions: Our findings confirm the presence of strains with higher in vitro pathogenicity during early HIV infection, suggesting that even among recently infected individuals, rapid progression may be a consequence of the early emergence of CXCR4-utilizing strains. Characterizing the HIV-1 V3 region by sequencing may be useful in predicting disease progression and guiding treatment initiation decisions.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein
    Puri, A
    Hug, P
    Jernigan, K
    Barchi, J
    Kim, HY
    Hamilton, J
    Wiels, J
    Murray, GJ
    Brady, RO
    Blumenthal, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) : 14435 - 14440
  • [42] Latency-associated DNA methylation patterns among HIV-1 infected individuals with distinct disease progression courses or antiretroviral virologic response
    Nathalia Mantovani
    Alexandre Defelicibus
    Israel Tojal da Silva
    Maira Ferreira Cicero
    Luiz Claudio Santana
    Rafael Arnold
    Daniela Funayama de Castro
    Rodrigo Lopes Sanz Duro
    Milton Yutaka Nishiyama-Jr
    Inácio Loiola Meirelles Junqueira-de-Azevedo
    Bosco Christiano Maciel da Silva
    Alberto José da Silva Duarte
    Jorge Casseb
    Simone de Barros Tenore
    James Hunter
    Ricardo Sobhie Diaz
    Shirley Cavalcante Vasconcelos Komninakis
    Scientific Reports, 11
  • [43] Latency-associated DNA methylation patterns among HIV-1 infected individuals with distinct disease progression courses or antiretroviral virologic response
    Mantovani, Nathalia
    Defelicibus, Alexandre
    da Silva, Israel Tojal
    Cicero, Maira Ferreira
    Santana, Luiz Claudio
    Arnold, Rafael
    de Castro, Daniela Funayama
    Sanz Duro, Rodrigo Lopes
    Nishiyama-Jr, Milton Yutaka
    Meirelles Junqueira-de-Azevedo, Inacio Loiola
    Maciel da Silva, Bosco Christiano
    da Silva Duarte, Alberto Jose
    Casseb, Jorge
    Tenore, Simone de Barros
    Hunter, James
    Diaz, Ricardo Sobhie
    Vasconcelos Komninakis, Shirley Cavalcante
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Impact of Δ32-CCR5 heterozygosity on HIV-1 genetic evolution and variability -: A study of 4 individuals infected with closely related HIV-1 strains
    Chalmet, Kristen
    Van Wanzeele, Filip
    Demecheleer, Els
    Dauwe, Kenny
    Pelgrom, Jolanda
    Van Der Gucht, Bea
    Vogelaers, Dirk
    Plum, Jean
    Stuyver, Lieven
    Vandekerckhove, Linos
    Verhofstede, Chris
    VIROLOGY, 2008, 379 (02) : 213 - 222
  • [45] Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil
    Sanabani, Sabri Saeed
    de Souza Pastena, Evelyn Regina
    da Costa, Antonio Charlys
    Martinez, Vanessa Pouza
    Kleine-Neto, Walter
    Soares de Oliveira, Ana Carolina
    Sauer, Mariana Melillo
    Bassichetto, Katia Cristina
    Santos Oliveira, Solange Maria
    Iwashita Tomiyama, Helena Tomoko
    Sabino, Ester Cerdeira
    Kallas, Esper Georges
    PLOS ONE, 2011, 6 (10):
  • [46] Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy
    Philpott, S
    Weiser, B
    Anastos, K
    Kitchen, CMR
    Robison, E
    Meyer, WA
    Sacks, HS
    Mathur-Wagh, U
    Brunner, C
    Burger, H
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (04): : 431 - 438
  • [47] Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals
    Zangerle, R
    Steinhuber, S
    Sarcletti, M
    Dierich, MP
    Wachter, H
    Fuchs, D
    Möst, J
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 116 (03) : 228 - 239
  • [48] Development of a Novel Codon-Specific Polymerase Chain Reaction for the Detection of CXCR4-Utilizing HIV Type 1 Subtype B
    McLaughlin, Sherry
    Swenson, Luke C.
    Hu, Shengbo
    Hughes, Paul
    Harrigan, P. Richard
    Coombs, Robert W.
    Frenkel, Lisa M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (05) : 814 - 825
  • [49] Evaluating a novel quantitative assay for HIV-1 VL among Chinese individuals infected with HIV
    Chang, Yue
    Zhu, Ting
    Miao, Yufei
    Zhu, Haiyin
    Hao, Zhixin
    Li, Taisheng
    Han, Yang
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (04)
  • [50] Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia
    Dvali, Natia
    Parker, Monica M.
    Chkhartishvili, Nikoloz
    Sharvadze, Lali
    Gochitashvili, Nino
    Abutidze, Akaki
    Karchava, Marine
    DeHovitz, Jack A.
    Tsertsvadze, Tengiz
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (07) : 1002 - 1008